Performant Financial - PFMT Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Performant Financial in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PFMT shares.
View PFMT analyst ratings or view top-rated stocks.

2 brokers have issued 1-year price objectives for Performant Financial's shares. Their PFMT share price forecasts range from $11.00 to $11.00. On average, they predict the company's stock price to reach $11.00 in the next year. This suggests a possible upside of 354.5% from the stock's current price.
View analysts price targets for PFMT or view top-rated stocks among Wall Street analysts.

Performant Financial's stock was trading at $2.41 on January 1st, 2022. Since then, PFMT stock has increased by 0.4% and is now trading at $2.42.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 21st 2023.
View our PFMT earnings forecast.

Performant Financial Co. (NASDAQ:PFMT) released its quarterly earnings results on Tuesday, November, 9th. The business services provider reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.05. The business services provider earned $28.58 million during the quarter. Performant Financial had a negative net margin of 7.94% and a negative trailing twelve-month return on equity of 10.59%. During the same period in the prior year, the firm earned $0.05 earnings per share.

51 employees have rated Performant Financial Chief Executive Officer Lisa Im on Glassdoor.com. Lisa Im has an approval rating of 53% among the company's employees. This puts Lisa Im in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Performant Financial investors own include OPKO Health (OPK), Actinium Pharmaceuticals (ATNM), BIOLASE (BIOL), AcelRx Pharmaceuticals (ACRX), Bank of America (BAC), Catalyst Biosciences (CBIO), Clean Energy Fuels (CLNE), Imunon (CLSN), Comstock Resources (CRK) and Edap Tms (EDAP).

Performant Financial trades on the NASDAQ under the ticker symbol "PFMT."

Performant Financial's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (3.47%), Kent Lake Capital LLC (1.45%), Parkman Healthcare Partners LLC (1.38%), Renaissance Technologies LLC (1.21%), Essex Investment Management Co. LLC (0.64%) and Trellus Management Company LLC (0.25%). Insiders that own company stock include Ecmc Group, Inc, Eric Yanagi, Parthenon Dcs Holdings, Llc, Pcp Managers Gp, Llc and Prescott Group Capital Managem.
View institutional ownership trends.

Shares of PFMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PFMT stock can currently be purchased for approximately $2.42.

Performant Financial (NASDAQ:PFMT) has a market capitalization of $179.76 million and generates $124.39 million in revenue each year. The business services provider earns $-10,290,000.00 in net income (profit) each year or ($0.12) on an earnings per share basis.

The company employs 929 workers across the globe.

Performant Financial's mailing address is 333 North Cayons Parkway, Livermore CA, 94551. The official website for the company is performantcorp.com. The business services provider can be reached via phone at (866) 256-0057, via email at investors@performantcorp.com, or via fax at 925-960-4880.